Huang Chong, You Chao
Department of Neurosurgery, West China Hospital, Chengdu, Sichuan, People's Republic of China.
Department of Neurosurgery, West China Hospital, Chengdu, Sichuan, People's Republic of China.
World Neurosurg. 2019 Jun;126:e545-e549. doi: 10.1016/j.wneu.2019.02.090. Epub 2019 Mar 1.
We investigated the outcomes of patients with an unruptured intracranial aneurysm (UIA) and >2 risk factors concerning complications, obliteration rate, and other factors after surgical or endovascular treatment.
Coiling and clipping were compared in patients with UIAs treated in West China Hospital from January 2015 to May 2017. Patient survival, dependency, retreatment, complications, and other clinical outcome indexes were compared between the 2 groups.
A total of 82 patients (92 aneurysms) had undergone treatment for UIAs with multiple risk factors. Of these 82 patients, 45 (54.9%) had undergone clipping and 37 (45.1%) had undergone coiling. No deaths were related to either treatment. Morbidity (modified Rankin scale score >2) at 1 year had developed in 1 of 45 and 1 of 37 patients in the clipping and coiling groups, without a statistically significant difference. Hospitalization >5 days (30 of 45 vs. 12 of 37; P < 0.05) was less frequent after coiling. The number of aneurysms with complete occlusion (48 of 51 vs. 33 of 41; P < 0.05) was greater in the surgical group. No differences in peritreatment complications were found in the surgical and endovascular groups (8 of 45 vs. 6 of 37; P > 0.05).
In our study, clipping and coiling showed advantages for the treatment of UIAs with multiple risk factors. Surgical clipping of UIAs is achievable with a low rate of unfavorable outcomes and a high rate of complete obliteration for patients with multiple risk factors. However, endovascular treatment was also successful, with a shorter length of stay and low procedure-related morbidity. Additional randomized evidence are required to support the superior efficacy of clipping.
我们研究了患有未破裂颅内动脉瘤(UIA)且有超过2个危险因素的患者在接受手术或血管内治疗后的并发症、闭塞率及其他因素的预后情况。
对2015年1月至2017年5月在华西医院接受治疗的UIA患者的栓塞和夹闭治疗进行比较。比较两组患者的生存情况、依赖程度、再次治疗情况、并发症及其他临床预后指标。
共有82例患者(92个动脉瘤)因多种危险因素接受了UIA治疗。在这82例患者中,45例(54.9%)接受了夹闭治疗,37例(45.1%)接受了栓塞治疗。两种治疗方式均未导致死亡。夹闭组和栓塞组在1年时的致残率(改良Rankin量表评分>2)分别为45例中的1例和37例中的1例,无统计学显著差异。栓塞治疗后住院时间>5天的情况较少(45例中的30例 vs. 37例中的12例;P<0.05)。手术组完全闭塞的动脉瘤数量更多(51例中的48例 vs. 41例中的33例;P<0.05)。手术组和血管内治疗组在治疗期间的并发症无差异(45例中的8例 vs. 37例中的6例;P>0.05)。
在我们的研究中,夹闭和栓塞治疗对于有多种危险因素的UIA均显示出优势。对于有多种危险因素的患者,手术夹闭UIA可实现不良预后发生率低且完全闭塞率高。然而,血管内治疗也取得了成功,住院时间较短且与手术相关的致残率低。需要更多随机对照证据来支持夹闭治疗的卓越疗效。